EQ Corporate is a Swiss-Mexican healthcare consulting firm that takes medical device, diagnostics (IVD) and pharmaceutical companies from market assessment to COFEPRIS registration, local representation and commercial launch in Mexico. We don't just advise, we execute.
-c7c2ac13.webp)
.jpg)
A healthcare consulting firm helps manufacturers plan and carry out entry into a regulated market. For Mexico, this typically includes regulatory pathway assessment, COFEPRIS sanitary registration, local legal representation, market and channel analysis, distributor selection and launch support. EQ Corporate covers each of these stages with teams in Switzerland and Mexico.
Yes. Foreign manufacturers need a legal representative domiciled in Mexico for sanitary registration and post-market obligations. EQ Corporate provides this local representation, so you can register and maintain products in Mexico without setting up your own Mexican entity.
Timelines depend on the product's risk class, the regulatory pathway (standard review or an abbreviated pathway based on a prior approval from a reference authority) and the completeness of the dossier. We give a product-specific timeline after the initial assessment. Our guide COFEPRIS explained: Mexico's FDA equivalent covers how classification and pathway shape the process.
In some cases. COFEPRIS offers abbreviated pathways (Vía Regulatoria Abreviada / reliance) for products already approved by certain reference authorities. Eligibility depends on the product and the specific approval held, so we confirm it product by product during the assessment.
Registration control is agreed with you from the start. We structure the registration so that control stays with the manufacturer rather than being tied to a single distributor, which keeps your options open if commercial partners change.
Fees depend on scope: the number and class of products, the regulatory pathway, and whether you also need representation, market research or distribution support. We define the scope after a free initial assessment and provide a written proposal before any work begins.
We work with medical device, diagnostics (IVD), medical and hospital equipment and pharmaceutical companies, mainly from Switzerland and Europe, including funded startups preparing for commercialization.
Yes, where it is strategically justified. Our distribution vertical provides local operations, logistics and access to public and private healthcare channels, so registration and commercialization are managed by one partner.
